The Structural Biology Shared Resource provides state-of-the-art infrastructure and expertise needed for high quality protein production and high resolution structure determination by NMR and X-ray crystallography. These capabilities are complemented by significant strengths in cryo-electron microscopy, electron paramagnetic resonance, a wide range of vibrational spectroscopies, computational biology and unique macromolecular foot printing approaches at the College and AECC. Through the New York Structural Genomics Research Consortium (NYSGRC), AECC investigators have access to -25-30 shifts (8 hour blocks) on the X29 insertion device at the National Synchrotron Light Source (NSLS), Brookhaven National Laboratory, as well as outstanding access to the LRL-CAT beamline (administered by Eli Lilly &Co.) at the Advanced Photon Source (APS), which provides FEDEX crystallographic service at one of the premiere beamlines in the world. Moreover, through membership in the New York Structural Biology Center, AECC investigators have access to the X4A bending magnet beamline at NSLS. These arrangements ensure that access to data collection resources is never rate limiting. There is also in-house Rigaku rotating anode/image plate data collection capabilities essential for characterization and screening of samples prior to synchrotron analysis. NMR capabilities at Einstein consists of one 300 MHz and two 600 MHz NMR spectrometers, with a cryoprobe on one of the 600s. AECC investigators also have full access to the NYSBC making available two 900 MHz and three 800 MHz instruments, all with cryoprobes, and one 750 MHz solid state NMR spectrometer. As proposed in the previous application, the Structural Biology Shared Resource has established unique capabilities, including considerable automation and expertise, which support large-scale and high-throughput protein production in E. coli, insect cell and mammalian expression platforms. Additional automation supports high-throughput protein crystallization and crystal imaging. The Facility is now working to implement modest fragment-based screening capabilities to leverage the numerous proteins and structures being produced, and is positioned to exploit NSLS-II, the new third generation synchrotron facility being constructed at Brookhaven National Laboratory. Together, these capabilities provide the AECC community with a powerful infrastructure that will make it possible to realize protein reagents and structural information to drive a wide range of biology and therapeutics.

Public Health Relevance

The Structural Biology Shared Resource provides unparalleled expertise and instrumentation for the production of protein reagents and high resolution structure determination to support the translational research mission and goals of the Albert Einstein Cancer Center (AECC). As an NCI-designated Cancer Center, AECC contributes to the national effort to reduce morbidity and mortality from cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013330-40
Application #
8582100
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-06-01
Project End
2018-06-30
Budget Start
2013-08-23
Budget End
2014-06-30
Support Year
40
Fiscal Year
2013
Total Cost
$136,784
Indirect Cost
$51,765
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Ruiz, Penelope D; Gamble, Matthew J (2018) MacroH2A1 chromatin specification requires its docking domain and acetylation of H2B lysine 20. Nat Commun 9:5143
Rohan, Thomas; Ye, Kenny; Wang, Yihong et al. (2018) MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One 13:e0191814
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Frimer, Marina; Miller, Eirwen M; Shankar, Viswanathan et al. (2018) Adjuvant Pelvic Radiation ""Sandwiched"" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. Int J Gynecol Cancer 28:1781-1788
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Lee, Chang-Hyun; Kiparaki, Marianthi; Blanco, Jorge et al. (2018) A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell 46:456-469.e4
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150

Showing the most recent 10 out of 1508 publications